ID
28152
Beschreibung
Study ID: 100601 Clinical Study ID: LPL100601 Study Title: LPL100601, A Clinical Outcomes Study of Darapladib versus Placebo in Subjects with Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00799903 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: darapladib Trade Name: darapladib Study Indication: Atherosclerosis Study part: Investigational product
Stichworte
Versionen (4)
- 21.09.17 21.09.17 -
- 13.10.17 13.10.17 -
- 23.10.17 23.10.17 -
- 22.12.17 22.12.17 -
Rechteinhaber
GlaxoSmithKline
Hochgeladen am
22. Dezember 2017
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY-NC 3.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Investigational product GSK study Chronic Coronary Heart Disease NCT00799903
Investigational product GSK study Chronic Coronary Heart Disease NCT00799903
Beschreibung
Investigational product discontinuation
Beschreibung
investigational product stopped permanently
Datentyp
text
Alias
- UMLS CUI [1,1]
- C0304229
- UMLS CUI [1,2]
- C0457454
Beschreibung
Select "Protocol deviation" if none of the other primary reasons are appropriate. Select "Decision by subject or proxy" if none of the other primary reasons are appropriate. In case of "Adverse Event", record details on the Non-Serious Adverse Events or Serious Adverse Events forms as appropriate. Check all that apply. If none, select "No Subreasons".
Datentyp
text
Alias
- UMLS CUI [1,1]
- C0392360
- UMLS CUI [1,2]
- C0013230
- UMLS CUI [1,3]
- C0457454
Beschreibung
Record details on the Non-Serious Adverse Events or Serious Adverse Events forms as appropriate. Check all that apply. If none, select "No Subreasons":
Datentyp
boolean
Alias
- UMLS CUI [1]
- C2699517
Beschreibung
Adverse event MACE
Datentyp
boolean
Alias
- UMLS CUI [1,1]
- C1516728
- UMLS CUI [1,2]
- C2826934
Beschreibung
Select this reason if none of the other primary reasons are appropriate.
Datentyp
text
Alias
- UMLS CUI [1]
- C1705236
Beschreibung
Select this reason if none of the other primary reasons are appropriate.
Datentyp
text
Alias
- UMLS CUI [1,1]
- C0422727
- UMLS CUI [1,2]
- C0679006
Beschreibung
Sponsor terminated study treatment specification
Datentyp
text
Alias
- UMLS CUI [1]
- C1710224
Beschreibung
Investigator site closed specification
Datentyp
text
Alias
- UMLS CUI [1]
- C2348235
Beschreibung
Post-IP Follow-up status
Beschreibung
Select type [1] if telephone follow-up was accepted by subject. Please complete TELE visit form for each contact. In case of type [2], please complete THIRD PARTY visit form for each contact. In case of type [3], please complete CONC form within EOS visit.
Datentyp
integer
Alias
- UMLS CUI [1,1]
- C0589121
- UMLS CUI [1,2]
- C0205272
Beschreibung
Fill in in case "Post-IP Phone Follow-up With Subject" or "Post-IP Follow-up through designated third party" has been selected.
Datentyp
text
Alias
- UMLS CUI [1]
- C3476109
Beschreibung
Contact frequency other
Datentyp
text
Alias
- UMLS CUI [1]
- C0337611
Beschreibung
Authorization status
Datentyp
text
Alias
- UMLS CUI [1,1]
- C0680281
- UMLS CUI [1,2]
- C0018724
Ähnliche Modelle
Investigational product GSK study Chronic Coronary Heart Disease NCT00799903
C0011008 (UMLS CUI [1,2])
C0040223 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,2])
C0040223 (UMLS CUI [1,2])
C0457454 (UMLS CUI [1,2])
C0013230 (UMLS CUI [1,2])
C0457454 (UMLS CUI [1,3])
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
C2826934 (UMLS CUI [1,2])
C0679006 (UMLS CUI [1,2])
C0205272 (UMLS CUI [1,2])
C0018724 (UMLS CUI [1,2])